CD96 and neoplasm: The modest but significant inhibition of T cell cytotoxicity supports earlier evidence that blocking CD96 in combination with other checkpoints promoted robust tumor control by murine CD8+ T cells, while blocking CD96 alone resulted in minimal tumor control by T cells [14].